PACS
PACS Group, Inc.
NYSE: PACS · HEALTHCARE · MEDICAL CARE FACILITIES
$31.90
-1.23% today
Updated 2026-06-05
Market cap
$5.74B
P/E ratio
23.41
P/S ratio
1.06x
EPS (TTM)
$1.55
Dividend yield
—
52W range
$8 – $43
Volume
0.9M
WallStSmart proprietary scores
60
out of 100
Grade: C+
Hold
Investment rating
8.7
Growth
A3.5
Quality
D6.0
Profitability
B5.7
Valuation
C+5/9
Piotroski F-Score
Moderate
1.4
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$49.17
+54.14%
12-Month target
$33.90
+6.27%
Intrinsic (DCF)
—
Margin of safety
—
2 Strong Buy4 Buy0 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ ROE 23.50% — strong efficiency
+ Free cash flow $214.51M — positive
+ Revenue growth 11.20% QoQ
Risks
- Altman Z 1.35 — distress zone
- Thin margins at 4.49%
- Debt/equity 3.38x — high leverage
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $2.42B | $3.11B | $4.09B | $5.29B | $5.43B |
| Net income | $150.50M | $112.87M | $55.76M | $191.54M | $80.69M |
| EPS | — | — | — | — | $1.55 |
| Free cash flow | $14.38M | $17.91M | $17.53M | $298.82M | $214.51M |
| Profit margin | 6.21% | 3.63% | 1.36% | 3.62% | 4.49% |
Peer comparison
Smart narrative
PACS Group, Inc. trades at $31.90. representing a P/E of 23.41x trailing earnings. Our Smart Value Score of 60/100 indicates the stock is good. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.35, it sits in the distress. TTM revenue stands at $5.43B. with profit margins at 4.49%.
Frequently asked questions
What is PACS Group, Inc.'s stock price?
PACS Group, Inc. (PACS) trades at $31.90, on a P/E of 23.4x and a P/S of 1.1x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is PACS Group, Inc. overvalued?
PACS Group, Inc. carries a Smart Value Score of 60/100 (Grade C+), which we rate Hold. That score blends growth, quality, and valuation into one read.
What is the price target of PACS Group, Inc. (PACS)?
The 12-month analyst consensus target is $49.17, about 54.1% above the current $31.90. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is PACS Group, Inc.'s revenue?
PACS Group, Inc.'s trailing twelve-month revenue is $5.43B. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
PACS Group, Inc.'s Altman Z-Score is 1.35, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio1.06x
ROE23.50%
Beta0.00
50D MA$35.49
200D MA$28.65
Shares out0.16B
Float0.05B
Short ratio—
Avg volume0.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—